Altered Hippocampal Muscarinic M4, but Not M1, Receptor Expression from Subjects with Schizophrenia

Biological Psychiatry

Volumn 61, Issue 10, 2007, Pages 1161-1170

  Scarr, Elizabeth ^a   Sundram, Suresh ^a,c   Keriakous, Dahlia ^a   Dean, Brian ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Northern Psychiatry Research Centre   (Australia)

Author keywords

Acetylcholine; hippocampus; human; postmortem; psychiatric disorders; receptors

Indexed keywords

BENZATROPINE; CHLORPROMAZINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M4 RECEPTOR; OLIGONUCLEOTIDE; PIMOZIDE; PIRENZEPINE H 3; PROCYCLIDINE; RADIOLIGAND; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE; TRIHEXYPHENIDYL; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; CADAVER; CAUSE OF DEATH; CONTROLLED STUDY; DEMOGRAPHY; DENTATE GYRUS; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA;

EID: 34247643222     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.08.050     Document Type: Article

References (43)

1. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25 (1997) 3389-3402
2. Ashby Jr. C.R., and Wang R.Y. Pharmacological actions of the atypical antipsychotic drug clozapine: A review. Synapse 24 (1996) 349-394
3. Bennett Jr. J.P., Enna S.J., Bylund D.B., Gillin J.C., Wyatt R.J., and Snyder S.H. Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 36 (1979) 927-934
4. Bird E.D., Spokes E.G., Barnes J., MacKay A.V., Iversen L.L., and Shepherd M. Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. Lancet 2 (1977) 1157-1158
5. Breese C.R., Lee M.J., Adams C.E., Sullivan B., Logel J., Gillen K.M., et al. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23 (2000) 351-364
6. Camps M., Cortes R., Gueye B., Probst A., and Palacios J.M. Dopamine receptors in human brain: Autoradiographic distribution of D2 sites. Neuroscience 28 (1989) 275-290
7. Cortes R., Gueye B., Pazos A., Probst A., and Palacios J.M. Dopamine receptors in human brain: Autoradiographic distribution of D1 sites. Neuroscience 28 (1989) 263-273
8. Crook J.M., Dean B., Pavey G., and Copolov D. The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia. Life Sci 64 (1999) 1761-1771
9. Crook J.M., Tomaskovic-Crook E., Copolov D.L., and Dean B. Decreased muscarinic receptor binding in subjects with schizophrenia: A study of the human hippocampal formation. Biol Psychiatry 48 (2000) 381-388
10. Crook J.M., Tomaskovic-Crook E., Copolov D.L., and Dean B. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: A study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Am J Psychiatry 158 (2001) 918-925
11. Dean B., Crook J.M., Opeskin K., Hill C., Keks N., and Copolov D.L. The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. Mol Psychiatry 1 (1996) 54-58
12. Dean B., Gray L., Keriakous D., and Scarr E. A comparison of M1 and M4 muscarinic receptors in the thalamus from control subjects and subjects with schizophrenia. Thalamus Related Systems 2 (2004) 287-295
13. Dean B., McLeod M., Keriakous D., McKenzie J., and Scarr E. Decreased muscarinic(1) receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 7 (2002) 1083-1091
14. Domino E.F., Krause R.R., and Bowers J. Various enzymes involved with putative neurotransmitters. Regional distribution in the brain of deceased mentally normal, chronic schizophrenics or organic brain syndrome patients. Arch Gen Psychiatry 29 (1973) 195-201
15. Falk L., Nordberg A., Seiger A., Kjaeldgaard A., and Hellstrom-Lindahl E. Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum. Neuroscience 132 (2005) 389-397
16. Fuller R.L., Luck S.J., McMahon R.P., and Gold J.M. Working memory consolidation is abnormally slow in schizophrenia. J Abnorm Psychol 114 (2005) 279-290
17. Hill C., Keks N., Roberts S., Opeskin K., Dean B., and Copolov D. Diagnostic Instrument for Brain Studies (1999), Mental Health Research Institute, Melbourne, Australia
18. Johnston D., and Amaral D.G.(. Hippocampus. In: Shepherd G.M. (Ed). The Synaptic Organization of the Brain. 4th ed (1998), Oxford University Press, New York 417-458
19. Kingsbury A.E., Foster O.J., Nisbet A.P., Cairns N., Bray L., Eve D.J., et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28 (1995) 311-318
20. Lahti R.A., Roberts R.C., Cochrane E.V., Primus R.J., Gallager D.W., Conley R.R., et al. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: A [3H]NGD-94-1 study. Mol Psychiatry 3 (1998) 528-533
21. Levey A.I. Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease. Proc Natl Acad Sci U S A 93 (1996) 13541-13546
22. Loiacono R.E., and Gruundlach A.L. In situ hybridisation histochemistry: Application to human brain tissue. In: Dean B., Kleinman J.E., and Hyde T.M. (Eds). Using CNS Tissue in Psychiatric Research: A Practical Guide (1999), Harwood Academic, Sydney 85-106
23. Mai J.K., Assheuer J., and Paxinos G. Atlas of the Human Brain (1997), Academic Press, San Diego, CA
24. Mancama D., Arranz M.J., Landau S., and Kerwin R. Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 119 (2003) 2-6
25. McGeer P.L., and McGeer E.G. Possible changes in striatal and limbic cholinergic systems in schizophrenia. Arch Gen Psychiatry 34 (1977) 1319-1323
26. Mishima K., Iwasaki K., Tsukikawa H., Matsumoto Y., Egashira N., Abe K., et al. The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats. Jpn J Pharmacol 84 (2000) 163-173
27. Moriya H., Takagi Y., Nakanishi T., Hayashi M., Tani T., and Hirotsu I. Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland. Life Sci 64 (1999) 2351-2358
28. Oades R.D., and Halliday G.M. Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res 434 (1987) 117-165
29. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., et al. Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison. Lancet 361 (2003) 281-288
30. Perry E.K., and Perry R.H. The cholinergic system in Alzheimer's disease. In: Roberts P.J. (Ed). Biochemistry of Dementia (1980), Wiley, Chichester, United Kingdom 153
31. Perry E.K., Perry R.H., Blessed G., and Tomlinson B.E. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 4 (1978) 273-277
32. Port R.L., and Seybold K.S. Hippocampal synaptic plasticity as a biological substrate underlying episodic psychosis. Biol Psychiatry 37 (1995) 318-324
33. Power A.E., Vazdarjanova A., and McGaugh J.L. Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem 80 (2003) 178-193
34. Raedler T.J., Knable M.B., Jones D.W., Urbina R.A., Gorey J.G., Lee K.S., et al. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am J Psychiatry 160 (2003) 118-127
35. Remington G.J. Antipsychotics (neuroleptics). In: Bezchlibnyk-Butler K.Z., and Jeffries J.J. (Eds). Clinical Handbook of Psychotropic drugs. 9th ed (1999), Hogrefe & Huber, Seattle, WA 55-84
36. Rodbard D. Mathematics and statistics of ligand assays. In: Langan J., and Clapp J.J. (Eds). Ligand Assay: Analysis of International Developments on Isotopic and Nonisotopic Immunoassay (1981), Masson, New York 55-101
37. Rouse S.T., Marino M.J., Potter L.T., Conn P.J., and Levey A.I. Muscarinic receptor subtypes involved in hippocampal circuits. Life Sci 64 (1999) 501-509
38. Scarr E., Gray L., Keriakous D., Robinson P.J., and Dean B. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar 1 disorder. Bipolar Disord 8 (2006) 133-143
39. Tzavara E.T., Bymaster F.P., Davis R.J., Wade M.R., Perry K.W., Wess J., et al. M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: Relevance to the pathophysiology and treatment of related CNS pathologies. FASEB J 18 (2004) 1410-1412
40. Tzavara E.T., Bymaster F.P., Felder C.C., Wade M., Gomeza J., Wess J., et al. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol Psychiatry 8 (2003) 673-679
41. Van der Zee E.A., and Luiten P.G. GABAergic neurons of the rat dorsal hippocampus express muscarinic acetylcholine receptors. Brain Res Bull 32 (1993) 601-609
42. Watanabe S., Nishikawa T., Takashima M., and Toru M. Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics. Life Sci 33 (1983) 2187-2196
43. Zavitsanou K., Katsifis A., Mattner F., and Xu-Feng H. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology 29 (2004) 619-625